Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group

BACKGROUND: Only a minority of prostate cancer patients with adverse pathology and biochemical recurrence (BCR) post radical prostatectomy (RP) experience metastasis and die from prostate cancer. Improved risk prediction models using genomic information may enable clinicians to better weigh the risk...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Badani, Ketan, Thompson, Darby J. S., Buerki, Christine, Davicioni, Elai, Garrison, Jill, Ghadessi, Mercedeh, Mitra, Anirban P., Wood, Penelope J., Hornberger, John
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2013
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3720607/
https://ncbi.nlm.nih.gov/pubmed/23592338
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires